Opsens : Management's Discussion & analysis for the year 202

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND


RESULTS OF OPERATIONS FOR THE YEAR ENDED AUGUST 31, 2023


The following...

Related Keywords

United Kingdom , Canada , Japan , United States , New Zealand , Quebec , Canadian , British , American , America , Edwards Lifesciences , Asia Pacific , Abiomed Impella , International Accounting Standards Board , Ministry Of Health , Aerospace Market , Haemonetics Corporation , Development Expenses , Opsens Inc , Health Canada Approval , Quebec Superior Court , Medtronic , Abiomed Inc , Nuclear Market , Quebec Inc , European Society Of Cardiology , Opsens Solutions Inc , Power Electronics , Abiomed , Distributor Sales , Opsens Solutions , International Financial Reporting Standards , International Accounting Standards , Fractional Flow Reserve , Quebec Superior , Middle East , Hyperemic Pressure Resting , New England Journal , European Society , Acute Coronary Syndromes , Valve Stenosis , Surgical Aortic Valve Replacement , North America , Cardiovascular Devices , Transcatheter Aortic Valve Replacement , Equipment Manufacturer , Power Electronics Markets , Artery Disease , Sales Force , Strategic Account , General Purchasing Organizations , Opsens Solution , Earnings Before Interest , Marketing Expenses , North American , Foreign Currency , Markets ,